Sign Up to like & get
recommendations!
0
Published in 2020 at "Cellular immunology"
DOI: 10.1016/j.cellimm.2020.104046
Abstract: Uncontrolled activation of NLRP3 inflammasome initiates a series of human inflammatory diseases. Targeting NLRP3 inflammasome has attracted considerable attention in developing potential therapeutic interventions. Here, we reported that dehydrocostus lactone (DCL), a main component of…
read more here.
Keywords:
dehydrocostus lactone;
inflammation;
asc oligomerization;
lps mediated ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Toxicology and applied pharmacology"
DOI: 10.1016/j.taap.2021.115582
Abstract: NLRP3 inflammasome is involved in several chronic inflammatory diseases. The inflammatory effect of the NLRP3 inflammasome is executed through IL-1β and IL-18. Therefore, IL-1β is one of the primary targets in chronic inflammatory conditions. However,…
read more here.
Keywords:
inflammasome activation;
asc oligomerization;
inhibits nlrp3;
safranal inhibits ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Scientific Reports"
DOI: 10.1038/srep41539
Abstract: Interleukin-1β (IL-1β) is a highly inflammatory cytokine that significantly contributes to both acute and chronic inflammatory diseases. The secretion of IL-1β requires a unique protease, caspase-1, which is activated by various protein platforms called inflammasomes.…
read more here.
Keywords:
asc oligomerization;
vasculitis;
quc;
inflammasome activation ... See more keywords